The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs.
Oakland, Calif.-based Kaiser Permanente, a major employer of physicians, has made big moves in the last few months: Here are nine moves since Oct. 1: ...
Some results have been hidden because they may be inaccessible to you